Audrey Hamilton

2.2k total citations · 1 hit paper
17 papers, 922 citations indexed

About

Audrey Hamilton is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Audrey Hamilton has authored 17 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Audrey Hamilton's work include Lymphoma Diagnosis and Treatment (7 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Cancer Treatment and Pharmacology (3 papers). Audrey Hamilton is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Cancer Treatment and Pharmacology (3 papers). Audrey Hamilton collaborates with scholars based in United States, Israel and Germany. Audrey Hamilton's co-authors include Leonard B. Saltz, Ki Y. Chung, Manish A. Shah, Dorothy W. Pan, David P. Kelsen, Lawrence B. Schwartz, Deborah Schrag, Nancy E. Kemeny, Jinru Shia and Gary K. Schwartz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Audrey Hamilton

16 papers receiving 899 citations

Hit Papers

Cetuximab Shows Activity in Colorectal Cancer Patients Wi... 2005 2026 2012 2019 2005 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
    2005 848 citations Ki Y. Chung, Jinru Shia et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Audrey Hamilton United States 4 783 418 195 138 108 17 922
Christopher Hagenstad United States 8 687 0.9× 297 0.7× 149 0.8× 168 1.2× 55 0.5× 14 847
Roger Sidhu United States 13 715 0.9× 388 0.9× 248 1.3× 139 1.0× 49 0.5× 29 904
V. Martin Switzerland 7 679 0.9× 349 0.8× 273 1.4× 193 1.4× 46 0.4× 10 804
Giovanna Marrapese Italy 7 911 1.2× 562 1.3× 301 1.5× 264 1.9× 71 0.7× 15 1.1k
Alexia Tellier France 4 869 1.1× 394 0.9× 170 0.9× 225 1.6× 75 0.7× 5 1.1k
J. Kalmus Germany 10 708 0.9× 294 0.7× 360 1.8× 117 0.8× 129 1.2× 22 1.0k
Yifah Yaron United States 11 615 0.8× 382 0.9× 146 0.7× 336 2.4× 88 0.8× 17 1.4k
E.U. Steinhauer Germany 6 860 1.1× 370 0.9× 145 0.7× 116 0.8× 89 0.8× 10 982
Tarek Chidiac United States 11 802 1.0× 384 0.9× 137 0.7× 207 1.5× 41 0.4× 16 1.0k
Lin Shen China 11 577 0.7× 443 1.1× 174 0.9× 152 1.1× 48 0.4× 33 829

Countries citing papers authored by Audrey Hamilton

Since Specialization
Citations

This map shows the geographic impact of Audrey Hamilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey Hamilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey Hamilton more than expected).

Fields of papers citing papers by Audrey Hamilton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey Hamilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey Hamilton. The network helps show where Audrey Hamilton may publish in the future.

Co-authorship network of co-authors of Audrey Hamilton

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey Hamilton. A scholar is included among the top collaborators of Audrey Hamilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey Hamilton. Audrey Hamilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Oresanya, Lawrence, et al.. (2023). Consolidation trends in vascular surgery. Journal of Vascular Surgery. 79(2). 412–417. 1 indexed citations
2.
Hamilton, Audrey, et al.. (2023). To report hounsfeld units or not: There is no question. The American Journal of Surgery. 229. 111–115. 1 indexed citations
3.
Green, Rebecca L., et al.. (2023). From Debt to Dollars: Assessing a General Surgeon's Career Value. Journal of Surgical Research. 291. 527–535. 2 indexed citations
4.
5.
Buege, Michael J., Phuong Dao, Philip Caron, et al.. (2021). Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience. Leukemia & lymphoma. 63(4). 876–884. 1 indexed citations
6.
Ghione, Paola, Erel Joffe, M. Lia Palomba, et al.. (2020). CD5-Positive Marginal Zone Lymphoma: Clinical Characteristics of the MSKCC Cohort, and Comparison with the CD5-Negative Population. Blood. 136(Supplement 1). 50–51. 3 indexed citations
7.
Borchmann, Sven, Erel Joffe, Craig H. Moskowitz, et al.. (2019). Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma. Blood. 133(20). 2121–2129. 26 indexed citations
8.
9.
Sermer, David, Santosha A. Vardhana, Connie Lee Batlevi, et al.. (2019). SAFETY AND EARLY DATA FROM A PHASE II TRIAL OF PEMBROLIZUMAB (PEM) AND ENTINOSTAT (ENT) IN RELAPSED AND REFRACTORY (R/R) HODGKIN LYMPHOMA (HL) AND FOLLICULAR LYMPHOMA (FL). Hematological Oncology. 37(S2). 331–332. 1 indexed citations
10.
Kumar, Anita, Andrew D. Zelenetz, Connie Lee Batlevi, et al.. (2018). Initial Results of a Phase II Study of Sequential Chemotherapy and Lenalidomide Followed By Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma. Blood. 132(Supplement 1). 2880–2880. 1 indexed citations
11.
Yu, Kenneth H., Simon Mantha, Robin Brenner, et al.. (2018). A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis. Annals of Oncology. 29. viii248–viii248. 1 indexed citations
12.
Hamilton, Audrey, et al.. (2017). Using Re-abstracted Hospital Medical Record Data to Assess the Accuracy of the SEER Database for Prostate Cancer Treatment. International Journal of Radiation Oncology*Biology*Physics. 99(2). E250–E250. 1 indexed citations
13.
Borchmann, Sven, Erel Joffe, Craig H. Moskowitz, et al.. (2017). Active Surveillance for Newly Diagnosed Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Blood. 130(Suppl_1). 654–654. 1 indexed citations
14.
Chung, Ki Y., Jinru Shia, Nancy E. Kemeny, et al.. (2005). Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry. Journal of Clinical Oncology. 23(9). 1803–1810. 848 indexed citations breakdown →
15.
Dellapasqua, Silvia, et al.. (2005). P82 Tailored chemotherapy trial for women at advancedage with endocrine nonresponsive breast cancer: the CASA Trial. The Breast. 14. S39–S39. 2 indexed citations
16.
Chen, Tai‐Tsang, A. Molina, Sanjay Goel, et al.. (2004). Epothilone B analog (BMS-247550) at the recommended phase II dose (RPTD) in patients (pts) with gynecologic (gyn) and breast cancers. Journal of Clinical Oncology. 22(14_suppl). 2115–2115. 16 indexed citations
17.
Hamilton, Audrey, et al.. (1999). Current Drug Therapy for Multiple Myeloma. Drugs. 57(4). 485–506. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Hagenstad Breakdown of academic impact, for papers by Roger Sidhu Breakdown of academic impact, for papers by V. Martin Breakdown of academic impact, for papers by Giovanna Marrapese Breakdown of academic impact, for papers by Alexia Tellier Breakdown of academic impact, for papers by J. Kalmus Breakdown of academic impact, for papers by Yifah Yaron Breakdown of academic impact, for papers by E.U. Steinhauer Breakdown of academic impact, for papers by Tarek Chidiac Breakdown of academic impact, for papers by Lin Shen
Rankless by CCL
2026